Breedervac-Reo-Plus (Canada)This page contains information on Breedervac-Reo-Plus for veterinary use.
The information provided typically includes the following:
- Breedervac-Reo-Plus Indications
- Warnings and cautions for Breedervac-Reo-Plus
- Direction and dosage information for Breedervac-Reo-Plus
Breedervac-Reo-PlusThis treatment applies to the following species:
BURSAL DISEASE-REOVIRUS VACCINE
Standard and Variant
READ IN FULL
BREEDERVAC-REO-PLUS is prepared using specific pathogen free (SPF) or approved substrates and contains Standard, GLS, and Delaware (A and E) strains of Infectious Bursal Disease virus, and two strains of avian reovirus (1733 and 2408) inactivated and suspended in the aqueous phase of an oil adjuvant emulsion.
Breedervac-Reo-Plus Indications For Use
BREEDERVAC-REO-PLUS is indicated for the vaccination of breeder replacement chickens against Infectious Bursal Disease, (Standard, Delaware and GLS variants) and disease caused by avian reoviruses. The IBD fraction is used primarily for early protection of progeny with maternal antibodies, and the Reovirus fraction is used to protect the breeder hen against tenosynovitis and the progeny against malabsorption. Chickens should be in good health when vaccinated. Sick or weak chickens will not develop adequate immunity.
The use of any inactivated vaccine may cause false positive results on Mycoplasma plate tests. Avoid Mycoplasma testing prior to ten weeks post-vaccination.
Breedervac-Reo-Plus Dosage And Administration
Allow the vaccine to reach ambient temperature, 16-27°C (60-80°F) before use and shake vigorously before and periodically during use. Inject 0.5 mL intramuscularly or subcutaneously in chickens at least 3 weeks old, using an 18 gauge x 1/2” or 1/4” needle.
Although this vaccine can be used for primary vaccination at three weeks of age or older, available evidence suggests that the best protection is obtained when it is used for revaccination of chickens previously immunized (primed) with the same type of live virus vaccines. Do not administer this vaccine during the critical egg laying period from onset until after peak production.
Examples: Breeder chickens.
Primary vaccination with modified live mild avian reovirus vaccine (TENSYNVAC®) prior to 12 weeks of age.
Primary vaccination with live bursal disease vaccine (CLONEVAC-D78®) prior to 12 weeks of age.
These primary vaccinations would then be followed by vaccination with BREEDERVAC-REO-PLUS at 16-22 weeks of age. A minimum of four weeks should elapse between the last live virus priming and injection with BREEDERVAC-REO-PLUS. Local conditions must be taken into consideration and, where necessary, veterinary advice should be sought.
It is evident that for optimal protection, preceding vaccination with live vaccines (priming) should have taken place. Generally, in flocks vaccinated with BREEDERVAC-REO-PLUS, a protective level of immunity will be achieved with only small variations between individual chickens.
This vaccine does not provoke clinical reactions in chickens. If shock is observed, this must usually be ascribed to the stress of handling.
Store in the dark in a refrigerator between 2-7°C (35-45°F). DO NOT FREEZE OR EXPOSE TO DIRECT SUNLIGHT.
PRECAUTIONS AND WARNINGS
1. TO AVOID HUMAN INJECTION, EXTREME CAUTION SHOULD BE USED WHEN INJECTING ANY OIL EMULSION VACCINE. ACCIDENTAL HUMAN INJECTION MAY CAUSE SERIOUS LOCAL REACTIONS. CONTACT A PHYSICIAN IMMEDIATELY IF ACCIDENTAL HUMAN INJECTION OCCURS.
2. If it is desired to vaccinate birds during lay, a drop in egg production may occur.
3. Do not administer this vaccine during the critical egg laying period from onset until after peak production.
4. Vaccinate market chickens by subcutaneous route only.
5. Injection of inactivated vaccine into breast muscle may create processing plant problems under certain conditions.
6. Do not vaccinate chickens within 42 days before slaughter.
7. Do not mix this vaccine with any other substances.
8. Use entire contents when first opened.
9. Ensure that vaccination equipment is clean and sterile before use.
10. Do not use vaccination equipment with rubber parts, as the oil emulsion may attack certain types of rubber.
11. FOR VETERINARY USE ONLY.
This vaccine has undergone rigid potency, safety and purity tests, and meets Intervet Inc. and USDA requirements. It is designed to stimulate effective immunity when used as directed, but the user must be advised that the response to the product depends upon many factors, including, but not limited to, conditions of storage and handling by the user, administration of the vaccine, health and responsiveness of the individual chickens, and the degree of field exposure. Therefore, directions should be followed carefully.
This product is not hazardous when used according to directions supplied. A material safety data sheet (MSDS) is available upon request. This and any other consumer information can be obtained by calling toll free Intervet Canada Corp. Customer Service at 1-866-683-7838.
Keep a record of vaccine, quantity, serial number, expiration date, place of purchase; the date and time of vaccination; the number, age, breed, and locations of chickens; names of operators performing the vaccination and any observed reactions.
500 ml - 1000 Doses
The use of this vaccine is subject to applicable local and federal laws and regulations.
USE ONLY AS DIRECTED
STORE VACCINE BETWEEN 2 AND 7°C (35 AND 45°F)
DO NOT FREEZE
THIS PRODUCT IS NON-RETURNABLE
INTERVET INC., Millsboro, Delaware U.S.A.
U.S. Veterinary License No. 165A
Made in U.S.A.
For technical enquiries, call toll free 1 888 306-0069.
NAC No.: 12081302
Intervet Canada Corp.
16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
|Fax:||Toll-free 888-498-4444; local 514-428-7014|
|Every effort has been made to ensure the accuracy of the Breedervac-Reo-Plus information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-10-31